Systemic delivery of the GnRH antagonist cetrorelix by intratracheal instillation in anesthetized rats

Author： Lizio R.   Klenner T.   Borchard G.   Romeis P.   Sarlikiotis A.W.   Reissmann T.   Lehr C.-M.  

Publisher： Elsevier

ISSN： 0928-0987

Source： European Journal of Pharmaceutical Sciences, Vol.9, Iss.3, 2000-01, pp. : 253-258

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment

By Roulier Roger   Chabert-Orsini Véronique   Sitri Marie-Christine   Barry Bernard   Terriou P  

Reproductive BioMedicine Online, Vol. 7, Iss. 2, 2003-09 ,pp. : 185-189

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Reproductive outcome using a GnRH antagonist (cetrorelix) for luteolysis and follicular synchronization in poor responder IVF/ICSI patients treated with a flexible GnRH antagonist protocol

By Humaidan P   Bungum L   Bungum M   Hald F   Agerholm I   Blaabjerg J   Andersen C Yding   Lindenberg S  

Reproductive BioMedicine Online, Vol. 11, Iss. 6, 2005-12 ,pp. : 679-684

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles - a prospective, randomized study

By Vlaisavljevic Veljko   Reljic Milan   Lovrec Vida Gavric   Kovacic Borut  

Reproductive BioMedicine Online, Vol. 7, Iss. 3, 2003-10 ,pp. : 301-308

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Outcome of cryopreserved pronuclear oocytes obtained after ovarian stimulation with either HMG or recFSH and the GnRH-antagonist cetrorelix

By Asimakopoulos Byron   Nikolettos Nikos   Al-Hasani Safaa  

Reproductive BioMedicine Online, Vol. 5, Iss. 3, 2002-11 ,pp. : 52-56

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing premature LH surges: report of two large multicentre, multinational, phase IIIb clinical experiences

By Olivennes F   Diedrich K   Frydman R   Felberbaum RE   Howles CM  

Reproductive BioMedicine Online, Vol. 6, Iss. 4, 2003-06 ,pp. : 432-438

Reproductive Healthcare Ltd

Access to resources Recommend Favorite